Pheton Holdings Return on Tangible Equity 1970-1969 | PTHL
Current and historical return on tangible equity values for Pheton Holdings (PTHL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Pheton Holdings Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.027B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $126.032B | 15.37 |
| Cencora (COR) | United States | $46.213B | 17.66 |
| ICON (ICLR) | Ireland | $24.133B | 21.69 |
| DiDi Global (DIDIY) | China | $18.810B | 0.00 |
| Avantor (AVTR) | United States | $18.267B | 27.70 |
| Natera (NTRA) | United States | $15.734B | 0.00 |
| Revvity (RVTY) | United States | $15.135B | 26.50 |
| Viatris (VTRS) | United States | $14.107B | 4.30 |
| CochLear (CHEOY) | Australia | $12.791B | 0.00 |
| Solventum (SOLV) | United States | $12.492B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.995B | 33.36 |
| Charles River Laboratories (CRL) | United States | $10.647B | 20.12 |
| Sonic Healthcare (SKHHY) | Australia | $8.854B | 0.00 |
| Doximity (DOCS) | United States | $7.456B | 47.25 |
| HealthEquity (HQY) | United States | $6.881B | 37.35 |
| Bausch + Lomb (BLCO) | Canada | $6.534B | 28.12 |
| PACS (PACS) | United States | $6.213B | 0.00 |
| Organon (OGN) | United States | $5.291B | 5.38 |
| Life Times (LTH) | United States | $4.879B | 40.78 |
| Sotera Health (SHC) | United States | $4.718B | 23.80 |
| Surgery Partners (SGRY) | United States | $3.989B | 44.20 |
| Concentras Parent (CON) | United States | $2.938B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.880B | 108.43 |
| BrightSpring Health Services (BTSG) | United States | $2.510B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.458B | 0.00 |
| Progyny (PGNY) | United States | $2.241B | 39.40 |
| Alignment Healthcare (ALHC) | United States | $2.234B | 0.00 |
| Premier (PINC) | United States | $2.057B | 9.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.980B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.751B | 8.79 |
| CareDx (CDNA) | United States | $1.589B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.560B | 0.00 |
| Agilon Health (AGL) | United States | $1.498B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.217B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.000B | 0.00 |
| Embecta (EMBC) | United States | $0.952B | 6.35 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.906B | 9.86 |
| InnovAge Holding (INNV) | United States | $0.807B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.532B | 0.00 |
| Sharecare (SHCR) | United States | $0.519B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.494B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 34.78 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.365B | 13.73 |
| Sera Prognostics (SERA) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.261B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| ModivCare (MODV) | United States | $0.192B | 6.09 |
| Ascend Wellness Holdings (AAWH) | United States | $0.191B | 0.00 |
| MultiPlan (MPLN) | United States | $0.168B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.086B | 20.73 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.082B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.042B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.65 |
| Singular Genomics Systems (OMIC) | United States | $0.040B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.040B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |